Pepticore

About

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Pepticore's primary focus in drug development?

Pepticore is focused on developing breakthrough innovations in anti-bacterial drugs.

What is the name of Pepticore's first product and what are its key characteristics?

Pepticore's first product is PheLiz, an antibiotic active against a wide range of bacterial and fungal species. It is designed to be effective against antibiotic-resistant microbial strains and exhibit resilience to microbial resistance due to its unique structure.

When was Pepticore founded?

Pepticore was founded in February 2024.

What is Pepticore's current funding stage?

Pepticore is currently in the Pre-Funding stage.

How many employees does Pepticore currently have?

Pepticore currently has between 1 and 10 employees.

What is Pepticore's relationship with Tarom Innovative Technologies?

Pepticore is a subsidiary of Tarom Innovative Technologies.

In which sector does Pepticore primarily operate?

Pepticore's primary sector is Health Tech & Life Sciences, specifically within Pharma & Medical Biotechnology.

What is the product stage of Pepticore's drug development?

Pepticore's product, PheLiz, is currently in the clinical trial stage.

Sectors & technology

Tags